特定于细胞类型的替代多基解促进了非小细胞肺癌进展中的瘤基因表达
Kexin Huang1,2,3, Yun Zhang1, Xiaorui Shi1
1School of Life Science and Technology, Xidian University, Xi'an, Shaanxi 710071, China.
Molecular therapy. Nucleic acids
|September 7, 2023
概括
破坏的替代多基化 (APA) 通过改变基因表达来影响癌症. 这项研究揭示了非小细胞肺癌 (NSCLC) 中细胞特异性APA事件,确定SPARC作为关键的瘤基因和潜在的治疗标.
科学领域:
- 分子生物学分子生物学
- 癌症研究 癌症研究
- 基因组学就是基因组学.
背景情况:
- 替代多氨基化 (APA) 失调与癌症的发展和进展有关.
- 了解细胞类型特定的APA事件对于发现新的癌症机制至关重要.
- 非小细胞肺癌 (NSCLC) 为研究APA驱动的基因调节提供了一个复杂的环境.
研究的目的:
- 为了在NSCLC和正常组织中的不同细胞类型中比较APA事件.
- 为了确定功能上显著的APA事件及其在NSCLC的预后价值.
- 阐明APA介导的3'-UTR改变在瘤基因调节和治疗反应中的作用.
主要方法:
- 在NSCLC和正常组织中对APA事件的比较分析.
- 在APA介导的3'-UTR缩短后,研究微RNA (miRNA) 结合位点动态.
- 对已识别的瘤基因-miRNA-瘤抑制轴的实验验证.
- 评估SPARC表达及其与耐药性和患者结局的相关性.
主要成果:
- 在NSCLC中确定了几种具有预后意义的细胞特异性3'-UTR变异.
- 由APA介导的3'-UTR缩短导致miRNA结合部位的丧失,影响基因表达.
- SPARC被确定为癌症相关纤维细胞中APA调节的瘤基因,促进NSCLC的入侵和转移.
- 高SPARC表达与对某些药物的耐药性相关,但表明西斯治疗的潜在益处.
结论:
- 细胞特异性APA事件在NSCLC中调节瘤基因表达方面发挥着关键作用.
- SPARC代表了一个潜在的治疗标,其表达影响了患者对西斯的反应.
- 这项研究提供了对APA驱动的监管机制的见解,并支持针对性和细胞特异性癌症疗法的开发.
相关概念视频
RNA Splicing
56.5K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.5K
Alternative RNA Splicing
21.3K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.3K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Chromatin Structure Regulates pre-mRNA Processing
7.0K
In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
The chromatin structure, especially...
7.0K


